To investigate the role of PRMT1 in CML LSCs (CD34+CD38−),[27] we first analyzed the expression of PRMT1 in CML LSCs and normal HSCs (CD34+CD38−)[27] derived from publicly available databases. This evidence concerns the gene CD34 and chronic myelogenous leukemia, BCR-ABL1 positive.